NovaBridge Biosciences (NBP) Change in Cash (2019 - 2025)
NovaBridge Biosciences (NBP) reported Change in Cash of -$17.4 million for Q4 2025, down 57.56% year-over-year from -$41.1 million in Q4 2024, and down 127.82% quarter-over-quarter from $62.7 million in Q3 2025.
NovaBridge Biosciences (NBP) Change in Cash (2019 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has 4 years of Change in Cash data on file, last reported at -$17.4 million in Q4 2025.
- Change in Cash for Q4 2025 came in at -$17.4 million, down 57.56% year-over-year; the trailing twelve-month figure through Dec 2025 was -$38.5 million (down 109.86% YoY), and the FY2025 annual result was $142.4 million, up 158.73% from the prior year.
- Change in Cash slipped to -$17.4 million in Q4 2025 per NBP's latest filing, from $62.7 million in the prior quarter.
- Over five years, Change in Cash peaked at $62.7 million in Q3 2025 and troughed at -$72.6 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -45.97 Mn |
| 10 | NovaBridge Biosciences | 328.19 Mn | 117.34 Mn | - | -17.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -17.43 Mn |
| Sep 30, 2025 | 62.66 Mn |
| Dec 31, 2024 | -11.06 Mn |
| Sep 30, 2024 | -72.63 Mn |
| Dec 31, 2020 | 271.42 Mn |
| Sep 30, 2020 | 202.27 Mn |
| Dec 31, 2019 | -12.45 Mn |